Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Balázs Ács
Veronika Zámbó
Laura Vízkeleti
A. Marcell Szász
Lilla Madaras
Gyöngyvér Szentmártoni
Tímea Tőkés
Béla Á. Molnár
István Artúr Molnár
Stefan Vári-Kakas
Janina Kulka
Anna-Mária Tőkés
机构：
[1] Semmelweis University,2nd Department of Pathology
[2] Semmelweis University,MTA
[3] MTA-TTK Lendület Cancer Biomarker Research Group,SE
[4] Semmelweis University,NAP Brain Metastasis Research Group
[5] Semmelweis University,Department of Clinical Oncology
[6] University of Oradea,1st Department of Surgery
[7] Romania,MTA
[8] Faculty of Electrical Engineering and Information Technology,SE Tumor Progression Research Group
[9] Semmelweis University,undefined
[10] 2nd Department of Pathology,undefined
来源：
Diagnostic Pathology | / 12卷
关键词：
Breast; Neoadjuvant chemotherapy; Ki-67; Predictive and prognostic markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Ki-67 as a prognostic marker according to breast cancer molecular subtype
    Nahed ASoliman
    Shaimaa MYussif
    Cancer Biology & Medicine, 2016, 13 (04) : 496 - 504
  • [22] Ki-67 as a prognostic marker according to breast cancer molecular subtype
    Soliman, Nahed A.
    Yussif, Shaimaa M.
    CANCER BIOLOGY & MEDICINE, 2016, 13 (04) : 496 - 504
  • [23] Prognostic significance of reduction rate of Ki-67 after neoadjuvant chemotherapy in breast cancer patients with non-pCR.
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Hosono, Ako
    Itoh, Kuniaki
    Fujii, Satoshi
    Yoneyama, Kimiyasu
    Wada, Noriaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Evaluation of pretherapeutic Ki67 as predictive marker for response to neoadjuvant chemotherapy in patients with primary breast cancer.
    Farr, Alex
    Weber, Myriam
    Pfeiler, Georg
    Oppolzer, Elisabeth
    Salama, Mohammed
    Bago-Horvath, Zsuzsanna
    Seifert, Michael
    Singer, Christian F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Can Ki-67 Play a Role in Prediction of Breast Cancer Patients' Response to Neoadjuvant Chemotherapy?
    Ingolf, Juhasz-Boss
    Russalina, Mavrova
    Simona, Moga
    Julia, Radosa
    Gilda, Schmidt
    Bohle, Rainer M.
    Andrea, Hasenfus
    Erich, Solomayer
    Daniel, Herr
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [26] Role of Ki-67 in Carcinoma Breast as Predictive Marker of Pathological Response to Neoadjuvant Chemotherapy: A Cross-sectional Study
    Vinie, Mathew Mary
    Anjit, Unnikrishnan
    Jose, Lovely
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (07) : 42 - 45
  • [27] Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
    Jain, Parveen
    Doval, Dinesh Chandra
    Batra, Ullas
    Goyal, Pankaj
    Bothra, Sneha Jatan
    Agarwal, Chaturbhuj
    Choudhary, Dutta Kumardeep
    Yadav, Abhishek
    Koyalla, Venkata Pradeep Babu
    Sharma, Mansi
    Dash, Prashanta
    Talwar, Vineet
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (04) : 329 - 338
  • [28] Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer
    Marme, F.
    Schneeweiss, A.
    Aigner, J.
    Eidt, S.
    Altevogt, P.
    Sinn, P.
    Wirtz, R. M.
    CANCER RESEARCH, 2012, 72
  • [29] The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis
    Chen, Xianyu
    He, Chao
    Han, Dongdong
    Zhou, Meirong
    Wang, Quan
    Tian, Jinhui
    Li, Lun
    Xu, Feng
    Zhou, Enxiang
    Yang, Kehu
    FUTURE ONCOLOGY, 2017, 13 (09) : 843 - 857
  • [30] Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy
    Yan, Hongjiang
    Wang, Renben
    Yu, Jinming
    Jiang, Shumei
    Zhu, Kunli
    Mu, Dianbin
    Xu, Zhongfa
    ONCOLOGY LETTERS, 2010, 1 (04) : 641 - 647
12345